Læknablaðið - 15.12.2011, Blaðsíða 16
RANNSÓKN
16. Tómasson K. Athugun á glöpum hjá öldruðum og
áfengissjúkum með auðveldu stöðluðu prófi borin saman
við mat starfsfólks. Læknablaðið 1986; 72: 246-59.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state".
A practical method for grading the cognitive state of
patients for the clinician. J Psychiatr Res 1975; 12:189-98.
18. Anthony JC, LeResche L, Niaz U, Korff M, Folstein M.
Limits of the "Mini-Mental State" as a screening test for
dementia and delirium among hospital patients. Psychol
Med 1982; 12:397-8.
19. Carrie AG, Grymonpre RE, Blandford AA. Impact of
Residence on prevalence and intensity of prescription
drug use among older adults. Geriatrics 2006; 40:1932-8.
20. Landlæknisembættið 2010; Ávísanir á lyfseðilsskyld lyf á
íslandi 2009. landlaeknir.is - október 2011.
21. Jans M, Hemández C, Vidal M, et al. Multidimensional
analysis of treatment adherence in patients with multiple
chronic conditions. A cross-sectional study in a tertiary
hospital. Patient Educ Couns 2010; 81:161-8.
22. Rikkala M, Hartikainen S, Sulkava R, Korhonen MJ.
Validity of the Finnish prescription register for measuring
psychotropics drug exposures among elderly Finns. A
population-based intervention study. Dmgs Aging 2010;
27:337-49.
ENGLISH SUMMARY
Medication use among community-dwelling older lcelanders. Population-based study in urban and rural
areas
Sigurdardottir AK, Arnadottir SA, Gunnarsdottir ED
Objective: To describe medication use among older community-dwelling lcelanders by collecting information on number of medicine, polypharmacy
(>5 medications), and medications by ATC categories. Moreover, to explore the relationship between medication use and various influential factors
emphasizing residency in urban and rural areas.
Material and methods: Population-based, cross-sectional study. Participants were randomly selected from the National registry in one urban (n=118)
and two rural (n=68) areas. Inclusion criteria: 1) a65 years old, 2) community-dwelling, 3) able to communicate verbally. Information on medication use
was obtained from each person’s medication list and interviews. A questionnaire and five standardized instruments were used to assess the potential
influencing factors.
Results: On average, participants used 3.9 medications and prevalence of polypharmacy was 41%. Men used 3.5 medications on average and women
4.4 (p=0.018). Compared to rural residents, urban residents had fewer medical diagnoses, better mobility, less pain, and fewer depressive symptoms.
By controlling for the effects of these variables, more medications were associated with urban living (p<0.001) and more medical diagnoses (p<0.001).
Likewise, adjusted odds for polypharmacy increased with urban residency (p=0.023) and more medical diagnoses (p=0.005). Urban residency, more
medical diagnoses, higher age, and male gender were related to use of drugs for blood and blood forming organs.
Conclusion: The results reveal an unexplained regional difference in medications use by older lcelanders. Further studies are required on why urban
residents use at least equal amount of medications as rural residents despite better scores on health assessments.
Keywords: Medicine use, elderly, ATC categorization, rural, urban
Correspondence: Árún K. Sigurðardóttir, arun@unak.is
680 LÆKNAblaðið 2011/97